HK-listed Lee’s Pharmaceutical unit nets $145m co-led by Hillhouse, TPG Asia

Zhaoke Ophthalmology Pharmaceutical (ZKO), an indirect subsidiary of Hong Kong-listed Lee’s Pharmaceutical Holdings Limited, has garnered as much as $145 million in its Series B round co-led by Hillhouse Capital’s Hillhouse COFL and TPG Asia, per a filing with the Stock Exchange of Hong Kong (HK

Read more: https://bit.ly/3dAE3CY

迴響已關閉。

在 WordPress.com 建立網站或網誌

向上 ↑

%d 位部落客按了讚: